Total Payments
$5,553
2024 Payments
$1,049
Companies
37
Transactions
295
Medicare Patients
6,616
Medicare Billing
$744,092
Payment Breakdown by Category
Food & Beverage$5,454 (98.2%)
Education$99.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,454 | 294 | 98.2% |
| Education | $99.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,259 | 75 | $0 (2024) |
| Lilly USA, LLC | $461.46 | 22 | $0 (2024) |
| GENZYME CORPORATION | $432.23 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $425.60 | 18 | $0 (2024) |
| Amgen Inc. | $345.84 | 15 | $0 (2024) |
| PFIZER INC. | $329.72 | 19 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $281.73 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $254.48 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $252.57 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $203.85 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 53 | Amgen Inc. ($178.46) |
| 2023 | $1,063 | 57 | AbbVie Inc. ($251.95) |
| 2022 | $681.59 | 38 | ABBVIE INC. ($203.45) |
| 2021 | $750.19 | 36 | AbbVie Inc. ($380.94) |
| 2020 | $618.88 | 29 | AbbVie Inc. ($130.84) |
| 2019 | $495.06 | 26 | AbbVie, Inc. ($96.04) |
| 2018 | $624.35 | 40 | Janssen Biotech, Inc. ($114.15) |
| 2017 | $271.10 | 16 | GENZYME CORPORATION ($37.21) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Immunology | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Immunology | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Immunology | ||||||
| 09/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: DERMATOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/13/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Immunology | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.53 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.24 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,339 | 4,397 | $688,102 | $233,387 |
| 2022 | 20 | 1,556 | 2,897 | $526,646 | $174,572 |
| 2021 | 20 | 1,337 | 2,367 | $555,296 | $176,065 |
| 2020 | 20 | 1,384 | 2,514 | $503,126 | $160,069 |
Total Patients
6,616
Total Services
12,175
Medicare Billing
$744,092
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 433 | 550 | $101,654 | $36,430 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 209 | 258 | $61,668 | $23,076 | 37.4% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 55 | 64 | $90,485 | $21,870 | 24.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 396 | 541 | $75,724 | $21,868 | 28.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 229 | 278 | $59,395 | $19,795 | 33.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 23 | 23 | $43,717 | $16,743 | 38.3% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 16 | 17 | $37,985 | $14,898 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 174 | 174 | $39,827 | $14,111 | 35.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 299 | 1,864 | $26,289 | $10,247 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 157 | 206 | $23,956 | $8,904 | 37.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 20 | 24 | $20,669 | $8,300 | 40.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 49 | 56 | $19,799 | $7,590 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 78 | $20,388 | $7,447 | 36.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 68 | 107 | $11,286 | $4,534 | 40.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 37 | $13,806 | $4,287 | 31.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $8,888 | $3,322 | 37.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $10,820 | $2,368 | 21.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 47 | 47 | $6,986 | $2,360 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,427 | $2,027 | 37.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 19 | $5,893 | $1,866 | 31.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 13 | $3,442 | $1,344 | 39.1% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2022 | 23 | 28 | $62,951 | $23,321 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 291 | 358 | $66,831 | $22,067 | 33.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 53 | 63 | $88,737 | $21,747 | 24.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 272 | 337 | $47,483 | $13,900 | 29.3% |
About Dr. Christopher Smith, M.D
Dr. Christopher Smith, M.D is a Dermatology healthcare provider based in Broomfield, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952393829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Smith, M.D has received a total of $5,553 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 295 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,454).
As a Medicare-enrolled provider, Smith has provided services to 6,616 Medicare beneficiaries, totaling 12,175 services with total Medicare billing of $744,092. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology, Dermatology
- Location Broomfield, CO
- Active Since 08/17/2005
- Last Updated 01/09/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952393829
Products in Payments
- SKYRIZI (Biological) $847.02
- DUPIXENT (Biological) $436.91
- TALTZ (Drug) $436.68
- EUCRISA (Drug) $329.72
- Otezla (Drug) $320.67
- Sotyktu (Drug) $254.48
- RINVOQ (Biological) $207.63
- REMICADE (Biological) $190.31
- Tremfya (Drug) $132.65
- DORYX (Drug) $126.42
- DUPIXENT (Drug) $112.18
- Cimzia (Drug) $96.14
- ILUMYA (Biological) $93.89
- HUMIRA (Biological) $90.40
- COSENTYX (Drug) $75.24
- TREMFYA (Drug) $67.97
- DUPIXENT DUPILUMAB INJECTION (Biological) $65.79
- Skyrizi (Biological) $61.77
- ABSORICA LD (Drug) $59.13
- Winlevi (Drug) $56.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.